These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2766281)
1. Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. Yang MB; Tamargo RJ; Brem H Cancer Res; 1989 Sep; 49(18):5103-7. PubMed ID: 2766281 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma. Lee JS; An TK; Chae GS; Jeong JK; Cho SH; Lee HB; Khang G Eur J Pharm Biopharm; 2005 Jan; 59(1):169-75. PubMed ID: 15567315 [TBL] [Abstract][Full Text] [Related]
3. Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea and tracers in the rabbit brain after interstitial delivery by biodegradable polymer implants. Strasser JF; Fung LK; Eller S; Grossman SA; Saltzman WM J Pharmacol Exp Ther; 1995 Dec; 275(3):1647-55. PubMed ID: 8531140 [TBL] [Abstract][Full Text] [Related]
4. Injection of chemotherapeutic microspheres and glioma. IV: Eradicating tumors in rats. Emerich DF; Winn SR; Bartus RT Cell Transplant; 2002; 11(1):47-54. PubMed ID: 12095219 [TBL] [Abstract][Full Text] [Related]
5. The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers. Grossman SA; Reinhard C; Colvin OM; Chasin M; Brundrett R; Tamargo RJ; Brem H J Neurosurg; 1992 Apr; 76(4):640-7. PubMed ID: 1545259 [TBL] [Abstract][Full Text] [Related]
6. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951 [TBL] [Abstract][Full Text] [Related]
7. Mast cells and tissue reaction to intraperitoneally implanted polymer capsules. Christenson L; Wahlberg L; Aebischer P J Biomed Mater Res; 1991 Sep; 25(9):1119-31. PubMed ID: 1778997 [TBL] [Abstract][Full Text] [Related]
8. The delivery of BCNU to brain tumors. Wang CC; Li J; Teo CS; Lee T J Control Release; 1999 Aug; 61(1-2):21-41. PubMed ID: 10469900 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Fung LK; Shin M; Tyler B; Brem H; Saltzman WM Pharm Res; 1996 May; 13(5):671-82. PubMed ID: 8860421 [TBL] [Abstract][Full Text] [Related]
10. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Tamargo RJ; Myseros JS; Epstein JI; Yang MB; Chasin M; Brem H Cancer Res; 1993 Jan; 53(2):329-33. PubMed ID: 8417826 [TBL] [Abstract][Full Text] [Related]
11. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860 [TBL] [Abstract][Full Text] [Related]
12. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122 [TBL] [Abstract][Full Text] [Related]
13. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168 [TBL] [Abstract][Full Text] [Related]
14. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267 [TBL] [Abstract][Full Text] [Related]
15. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model. Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer. Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190 [TBL] [Abstract][Full Text] [Related]
17. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer. Hsu TT; Langer R J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain. Brem H; Tamargo RJ; Olivi A; Pinn M; Weingart JD; Wharam M; Epstein JI J Neurosurg; 1994 Feb; 80(2):283-90. PubMed ID: 8283268 [TBL] [Abstract][Full Text] [Related]
19. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Bullard DE; Bigner SH; Bigner DD Cancer Res; 1985 Nov; 45(11 Pt 1):5240-5. PubMed ID: 4053004 [TBL] [Abstract][Full Text] [Related]
20. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea. Sano Y; Hoshino T; Barker M; Deen DF Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]